Compounds > 4-aminopyridine

4-aminopyridine and laquinimod

4-aminopyridine has been researched along with laquinimod in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fox, EJ1
Ais-Larisgoitia, A; de Lorenzo-Pinto, A; Rodríguez-González, CG1

Reviews

2 review(s) available for 4-aminopyridine and laquinimod

ArticleYear
Emerging oral agents for multiple sclerosis.
    The American journal of managed care, 2010, Volume: 16, Issue:8 Suppl

    Topics: 4-Aminopyridine; Cladribine; Clinical Trials as Topic; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Multiple Sclerosis; Propylene Glycols; Quinolones; Sphingosine

2010
[Emerging therapies for multiple sclerosis].
    Medicina clinica, 2013, Jan-19, Volume: 140, Issue:2

    Topics: 4-Aminopyridine; Administration, Oral; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Cladribine; Clinical Trials as Topic; Crotonates; Daclizumab; Dimethyl Fumarate; Fingolimod Hydrochloride; Fumarates; Humans; Hydroxybutyrates; Immunoglobulin G; Immunosuppressive Agents; Middle Aged; Multicenter Studies as Topic; Multiple Sclerosis; Nitriles; Propylene Glycols; Quinolones; Rituximab; Sphingosine; Toluidines; Young Adult

2013